Dosing Strategies for Lithium Monotherapy in Children and Adolescents with Bipolar I Disorder
- 1 June 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 21 (3) , 195-205
Abstract
Objective: The primary goal of this exploratory study was to obtain data that could lead to evidence-based dosing strategies for lithium in children and adolescents suffering from bipolar I disorder. Methods: Outpatients aged 7–17 years meeting Diagnostic and Statistical Manual of Mental Disorders , 4th edition, diagnostic criteria for bipolar I disorder (manic or mixed) were eligible for 8 weeks of open label treatment with lithium in one of three dosing arms. In Arm I, participants began treatment at a dose of 300 mg of lithium twice daily. The starting dose of lithium in Arms II and III was 300 mg thrice daily. Patients in Arms I and II could have their dose increased by 300 mg/day, depending on clinical response, at weekly visits. Patients in Arm III also had mid-week telephone interviews after which they could also have their dose of lithium increased by 300 mg per day. Youths weighing A priori response criteria were defined as a Clinical Global Impressions-Improvement scale score of ≤2 and a 50% decrease from baseline on the Young Mania Rating Scale. Results: Of the 61 youths [32 males (52.5%)] who received open-label lithium, 60 youths completed at least 1 week of treatment and returned for a postbaseline assessment. Most patients had a ≥50% improvement in Young Mania Rating Scale score, and more than half of the patients (58%) achieved response. Overall, lithium was well tolerated. All three treatment arms had similar effectiveness, side effect profiles, and tolerability of lithium. Conclusions: On the basis of these results, a dosing strategy in which pediatric patients begin lithium at a dose of 300 mg thrice daily (with an additional 300 mg increase during the first week), followed by 300 mg weekly increases until a priori stopping criteria are met, will be used in an upcoming randomized, placebo-controlled trial.Keywords
This publication has 41 references indexed in Scilit:
- First-Dose Pharmacokinetics of Lithium Carbonate in Children and AdolescentsJournal of Clinical Psychopharmacology, 2010
- The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementationChild and Adolescent Psychiatry and Mental Health, 2008
- The Nisonger Child Behavior Rating Form: typical IQ versionInternational Clinical Psychopharmacology, 2008
- Pharmacotherapy of Mood DisordersAnnual Review of Clinical Psychology, 2008
- Clinical correlates of bipolar disorder in a large, referred sample of children and adolescentsJournal of Psychiatric Research, 2005
- A Revised Anchored Version of the BPRS-C for Childhood Psychiatric DisordersJournal of Child and Adolescent Psychopharmacology, 2001
- The Caregiver Strain QuestionnaireJournal of Emotional and Behavioral Disorders, 1997
- Serum Concentration and Clinical Supervision in Monitoring of Lithium TreatmentTherapeutic Drug Monitoring, 1980
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970